|
Peptide receptor radionuclide therapy of treatment-refractory metastatic thyroid cancer using (90)Yttrium and (177)Lutetium labeled somatostatin analogs: toxicity, response and survival analysis
|
11 February 2015 |
|
Somatostatin receptors in gastrointestinal stromal tumors: new prognostic biomarker and potential therapeutic strategy
|
10 February 2015 |
|
Retinoic acid and cancer treatment
|
10 February 2015 |
|
Potential role of melatonin in prevention and treatment of oral carcinoma
|
10 February 2015 |
|
Melatonin and cancer
|
09 February 2015 |
|
Role of melatonin in cancer treatment
|
27 January 2015 |
|
Retinoids and their biological effects against cancer
|
23 January 2015 |
|
Retinoids: novel immunomodulators and tumour-suppressive agents?
|
23 January 2015 |
|
Melatonin Attenuates Her-2, p38 MAPK, p-AKT, and mTOR Levels in Ovarian Carcinoma of Ethanol-Preferring Rats
|
20 January 2015 |
|
Impact of long-acting octreotide in patients with early-stage MEN1-related duodeno-pancreatic neuroendocrine tumours
|
19 January 2015 |